Myc inhibition impairs autophagosome formation

Human Molecular Genetics

Volumn 22, Issue 25, 2013, Pages 5237-5248

  Toh, Pearl P C ^a   Luo, Shouqing ^a,c   Menzies, Fiona M ^a   Raskó, Tamás ^b   Wanker, Erich E ^b   Rubinsztein, David C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLIN 1; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MYC PROTEIN; PROTEIN BCL 2; PROTEIN P62; REACTIVE OXYGEN METABOLITE; S6 KINASE; STRESS ACTIVATED PROTEIN KINASE 1;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CANCER CHEMOTHERAPY; CELL SURVIVAL; CELL VIABILITY; ENZYME ACTIVATION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; MOLECULARLY TARGETED THERAPY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 8; MOLECULAR TARGETED THERAPY; NEOPLASMS; PHAGOSOMES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; REACTIVE OXYGEN SPECIES;

EID: 84888778602     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt381     Document Type: Article

References (54)

1. Ravikumar, B., Sarkar, S., Davies, J.E., Futter, M., Garcia-Arencibia, M., Green-Thompson, Z.W., Jimenez-Sanchez, M., Korolchuk, V.I., Lichtenberg, M., Luo, S. et al. (2010) Regulation of mammalian autophagy in physiology and pathophysiology. Physiol. Rev., 90, 1383-1435.
2. Yang, Z. and Klionsky, D.J. (2010) Eaten alive: a history of macroautophagy. Nat. Cell Biol., 12, 814-822.
3. Mizushima, N. (2010) The role of the Atg1/ULK1 complex in autophagy regulation. Curr. Opin. Cell Biol., 22, 132-139.
4. Williams, A., Sarkar, S., Cuddon, P., Ttofi, E.K., Saiki, S., Siddiqi, F.H., Jahreiss, L., Fleming, A., Pask, D., Goldsmith, P. et al. (2008) Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat. Chem. Biol., 4, 295-305.
5. Sarkar, S., Davies, J.E., Huang, Z., Tunnacliffe, A. and Rubinsztein, D.C. (2007) Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J. Biol. Chem., 282, 5641-5652.
6. Wei, Y., Pattingre, S., Sinha, S., Bassik, M. and Levine, B. (2008) JNK1-mediated Phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol. Cell., 30, 678-688.
7. Liang, X.H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H. and Levine, B. (1999) Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature, 402, 672-676.
8. Liang, C., Feng, P., Ku, B., Dotan, I., Canaani, D., Oh, B.H. and Jung, J.U. (2006) Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat. Cell. Biol., 8, 688-699.
9. Marino, G., Salvador-Montoliu, N., Fueyo, A., Knecht, E., Mizushima, N. and Lopez-Otin, C. (2007) Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. J. Biol. Chem., 282, 18573-18583.
10. Degenhardt, K., Mathew, R., Beaudoin, B., Bray, K., Anderson, D., Chen, G., Mukherjee, C., Shi, Y., Gelinas, C., Fan, Y. et al. (2006) Autophagy promotes tumor cell survival and restricts necrosis, inflammation and tumorigenesis. Cancer Cell, 10, 51-64.
11. Karantza-Wadsworth, V., Patel, S., Kravchuk, O., Chen, G.,Mathew, R., Jin, S. and White, E. (2007) Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev., 21, 1621-1635.
12. Paglin, S., Hollister, T., Delohery, T., Hackett, N., McMahill, M., Sphicas, E., Domingo, D. and Yahalom, J. (2001) A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res., 61, 439-444.
13. Kondo, Y., Kanzawa, T., Sawaya, R. and Kondo, S. (2005) The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer, 5, 726-734.
14. Shachaf, C.M., Kopelman, A.M., Arvanitis, C., Karlsson, A., Beer, S., Mandl, S., Bachmann, M.H., Borowsky, A.D., Ruebner, B., Cardiff, R.D. et al. (2004) MYC Inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature, 431, 1112-1117.
15. D'Cruz, C.M., Gunther, E.J., Boxer, R.B., Hartman, J.L., Sintasath, L., Moody,S.E., Cox, J.D., Ha, S.I., Belka, G.K., Golant,A. et al. (2001)c-MYC inducesmammarytumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat. Med., 7, 235-239.
16. Amati, B., Alevizopoulos, K. and Vlach, J. (1998) Myc and the cell cycle. Front. Biosci., 3, d250-d268.
17. Felsher, D.W. (2010) MYC Inactivation elicits oncogene addiction through both tumor cell-intrinsic and host-dependent mechanisms. Genes Cancer, 1, 597-604.
18. Wang, Y.H., Liu, S., Zhang, G., Zhou, C.Q., Zhu, H.X., Zhou, X.B., Quan, L.P., Bai, J.F. and Xu, N.Z. (2005) Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. Breast Cancer Res., 7, R220-R228.
19. Iversen, P.L., Arora, V., Acker, A.J., Mason, D.H. and Devi, G.R. (2003) Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans. Clin. Cancer Res., 9, 2510-2519.
20. Soucek, L., Whitfield, J., Martins, C.P., Finch, A.J., Murphy, D.J., Sodir, N.M., Karnezis, A.N., Swigart, L.B., Nasi, S. and Evan, G.I. (2008) Modelling Myc inhibition as a cancer therapy. Nature, 455, 679-683.
21. Delmore, J.E., Issa, G.C., Lemieux, M.E., Rahl, P.B., Shi, J., Jacobs, H.M., Kastritis, E., Gilpatrick, T., Paranal, R.M., Qi, J. et al. (2011) BET Bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell, 146, 904-917.
22. Balakumaran, B.S., Porrello, A., Hsu, D.S., Glover, W., Foye, A., Leung, J.Y., Sullivan, B.A., Hahn, W.C., Loda, M. and Febbo, P.G. (2009) MYC Activity mitigates response to rapamycin in prostate cancer through eukaryotic initiation factor 4E-binding protein 1-mediated inhibition of autophagy. Cancer Res., 69, 7803-7810.
23. Takahashi, Y., Hori, T., Cooper, T.K., Liao, J., Desai, N., Serfass, J.M., Young, M.M., Park, S., Izu, Y. and Wang, H.G. (2013) Bif-1 haploinsufficiency promotes chromosomal instability and accelerates Myc-driven lymphomagenesis via suppression of mitophagy. Blood, 121, 1622-1632.
24. Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y. and Yoshimori, T. (2000) LC3, A mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J., 19, 5720-5728.
25. Menzies, F.M., Moreau, K., Puri, C., Renna, M. and Rubinsztein, D.C. (2012) Measurement of autophagic activity in mammalian cells. Curr. Protoc. Cell Biol., Chapter 15, Unit 15.16.
26. Yamamoto, A., Tagawa, Y., Yoshimori, T., Moriyama, Y., Masaki, R. and Tashiro, Y. (1998) Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct. Funct., 23, 33-42.
27. Gomez-Curet, I., Perkins, R.S., Bennett, R., Feidler, K.L., Dunn, S.P. and Krueger, L.J. (2006) c-Myc inhibition negatively impacts lymphoma growth. J. Pediatr. Surg., 41, 207-211; discussion 207-211.
28. Axe, E.L., Walker, S.A., Manifava, M., Chandra, P., Roderick, H.L., Habermann, A., Griffiths, G. and Ktistakis, N.T. (2008) Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J. Cell Biol., 182, 685-701.
29. Komatsu, M., Waguri, S., Koike, M., Sou, Y.S., Ueno, T., Hara, T., Mizushima, N., Iwata, J., Ezaki, J., Murata, S. et al. (2007) Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell, 131, 1149-1163.
30. Bjorkoy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Overvatn, A., Stenmark, H. and Johansen, T. (2005) P62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol., 171, 603-614.
31. BenYounes, A., Tajeddine, N., Tailler, M., Malik, S.A., Shen, S., Metivier, D., Kepp, O., Vitale, I., Maiuri, M.C. and Kroemer, G. (2011) A fluorescence-microscopic and cytofluorometric system for monitoring the turnover of the autophagic substrate p62/SQSTM1. Autophagy, 7, 883-891.
32. Kuusisto, E., Suuronen, T. and Salminen, A. (2001) Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells. Biochem. Biophys. Res. Commun., 280, 223-228.
33. Hamano, T., Gendron, T.F., Causevic, E., Yen, S.H., Lin, W.L., Isidoro, C., Deture, M. and Ko, L.W. (2008) Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression. Eur. J. Neurosci., 27, 1119-1130.
34. Marquez, R.T. and Xu, L. (2012) Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch. Am. J. Cancer Res., 2, 214-221.
35. Komiya, K., Uchida, T., Ueno, T., Koike, M., Abe, H., Hirose, T.,Kawamori, R., Uchiyama, Y., Kominami, E., Fujitani, Y. et al. (2010) Free fatty acids stimulate autophagy in pancreatic beta-cells via JNK pathway. Biochem. Biophys. Res. Commun., 401, 561-567.
36. Vlahopoulos, S. and Zoumpourlis, V.C. (2004) JNK: a key modulator of intracellular signaling. Biochemistry (Mosc.), 69, 844-854.
37. Underwood, B.R., Imarisio, S., Fleming, A., Rose, C., Krishna, G., Heard, P., Quick, M., Korolchuk, V.I., Renna, M., Sarkar, S. et al. (2010) Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease. Hum. Mol. Genet., 19, 3413-3429.
38. Chen, Y., Azad, M.B. and Gibson, S.B. (2009) Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ., 16, 1040-1052.
39. Gao, M., Yeh, P.Y., Lu, Y.S., Hsu, C.H., Chen, K.F., Lee, W.C., Feng, W.C., Chen, C.S., Kuo, M.L. and Cheng, A.L. (2008) OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma. Cancer Res., 68, 9348-9357.
40. Meyer, N. and Penn, L.Z. (2008) Reflecting on 25 years withMYC.Nat. Rev. Cancer, 8, 976-990.
41. Kisen, G.O., Tessitore, L., Costelli, P., Gordon, P.B., Schwarze, P.E., Baccino, F.M. and Seglen, P.O. (1993) Reduced autophagic activity in primary rat hepatocellular carcinoma and ascites hepatoma cells. Carcinogenesis, 14, 2501-2505.
42. Gozuacik, D. and Kimchi, A. (2004) Autophagy as a cell death and tumor suppressor mechanism. Oncogene, 23, 2891-2906.
43. Amaravadi, R.K., Yu, D., Lum, J.J., Bui, T., Christophorou, M.A., Evan, G.I., Thomas-Tikhonenko, A. and Thompson, C.B. (2007) Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest., 117, 326-336.
44. Tsuneoka, M., Umata, T., Kimura, H., Koda, Y., Nakajima, M., Kosai, K., Takahashi, T., Takahashi, Y. and Yamamoto, A. (2003) c-myc induces autophagy in rat 3Y1 fibroblast cells. Cell Struct. Funct., 28, 195-204.
45. Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K. and Nevins, J.R. (2000) Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev., 14, 2501-2514.
46. Mateyak, M.K., Obaya, A.J., Adachi, S. and Sedivy, J.M. (1997) Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ., 8, 1039-1048.
47. Mizushima, N., Yamamoto, A., Hatano, M., Kobayashi, Y., Kabeya, Y., Suzuki, K., Tokuhisa, T., Ohsumi, Y. and Yoshimori, T. (2001) Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J. Cell Biol., 152, 657-668.
48. Lei, K., Nimnual, A., Zong, W.X., Kennedy, N.J, Flavell, R.A., Thompson, C.B., Bar-Sagi, D. and Davis, R.J. (2002) The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)- terminal kinase. Mol. Cell Biol., 22, 4929-4942.
49. Bampton, E.T., Goemans, C.G., Niranjan, D., Mizushima, N. and Tolkovsky, A.M. (2005) The dynamics of autophagy visualized in live cells: from autophagosome formation to fusion with endo/lysosomes. Autophagy, 1, 23-36.
50. Larsen, K.B., Lamark, T., Overvatn, A., Harneshaug, I., Johansen, T. and Bjorkoy, G. (2010) A reporter cell system to monitor autophagy based on p62/SQSTM1. Autophagy, 6, 784-793.
51. Ricci, M.S., Jin, Z., Dews, M., Yu, D., Thomas-Tikhonenko, A., Dicker, D.T. and El-Deiry, W.S. (2004) Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity. Mol. Cell Biol., 24, 8541-8555.
52. Min, S.W., Cho, S.H., Zhou, Y., Schroeder, S., Haroutunian, V., Seeley, W.W., Huang, E.J., Shen, Y., Masliah, E., Mukherjee, C. et al. (2010) Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron, 67, 953-966.
53. Luo, S. and Rubinsztein, D.C. (2010) Apoptosis blocks Beclin 1-dependent autophagosome synthesis: an effect rescued by Bcl-xL. Cell Death Differ., 17, 268-277.
54. Jimenez-Sanchez, M., Menzies, F.M., Chang, Y.Y., Simecek, N., Neufeld, T.P. and Rubinsztein, D.C. (2012) The Hedgehog signalling pathway regulates autophagy. Nat. Commun., 3, 1200.